ctrl K

Price Alert

Alnylam Pharmaceuticals I... (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

449.02

6.29 (1.42%)

At close: Aug 15, 2025, 3:59 PM

448.00

-0.23%

After-hours: Aug 15, 2025, 05:30 PM EDT

Alnylam Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	966.43M	812.69M	866.39M	819.98M
Short-Term Investments	1.73B	1.63B	1.33B	1.62B
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	133.9M	111.29M	115.48M	101.09M
Receivables	405.31M	327.79M	237.96M	198.57M
Inventory	78.51M	89.15M	128.96M	86.36M
Other Current Assets	116.96M	126.38M	132.92M	n/a
Total Current Assets	3.3B	2.98B	2.69B	2.81B
Property-Plant & Equipment	693.93M	725.79M	738.63M	733.63M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	944.7M	847.18M	854.11M	834.73M
Total Assets	4.24B	3.83B	3.55B	3.64B
Account Payables	88.42M	55.52M	98.09M	73.43M
Deferred Revenue	55.48M	102.75M	42.1M	149.48M
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	327.42M	177.16M	170.98M	130.66M
Total Current Liabilities	1.19B	967.79M	767.91M	695.71M
Long-Term Debt	1.02B	1.02B	1.02B	675.7M
Other Long-Term Liabilities	1.73B	1.63B	1.46B	1.25B
Total Long-Term Liabilities	2.99B	3.08B	2.94B	2.36B
Total Liabilities	4.17B	4.05B	3.7B	3.06B
Total Debt	1.3B	1.31B	1.32B	997.59M
Common Stock	1.29M	1.26M	1.24M	1.2M
Retained Earnings	-7.29B	-7.01B	-6.57B	-5.44B
Comprehensive Income	-34.52M	-23.38M	-44.65M	-33.26M
Shareholders Equity	67.09M	-220.64M	-158.22M	588.2M
Total Investments	1.73B	1.63B	1.33B	1.62B